The impact of antiviral therapy on hepatocellular carcinoma epidemiology
The development of nucleos(t)ide analogs and direct antiviral agents has revolutionized the management of chronic infection with HBV and HCV, respectively. These regimens allow to expand treatment to virtually all infected, including those with poor hepatic reserve and those with severe comorbiditie...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2018-01-01
|
| Edice: | Hepatic Oncology |
| Témata: | |
| On-line přístup: | https://www.futuremedicine.com/doi/10.2217/hep-2017-0024 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|